Short report

High RBM3 expression in prostate cancer independently predicts a reduced risk of biochemical recurrence and disease progression

Last 30 days: 71 accesses
Last 365 days: 820 accesses
All time: 1561 accesses

Liv Jonsson^*, Alexander Gaber, David Ulmert, Mathias Uhlén, Anders Bjartell and Karin Jirström

Diagnostic Pathology 2011, 6:91 doi:10.1186/1746-1596-6-91

Accesses